Relativity Logo
    Relativity
    Relativity Logo
    Relativity
    IdeasPortfolios
    Companies/ZVRA

    Zevra Therapeutics, Inc.(ZVRA)

    Biotechnology
    Rare Disease / Orphan Drug
    BusinessManagementInsider TradingIndustryFinancialsTranscripts
    Company Summary Stats
    H.BearBearishNeutralBullishH.Bull
    53.5
    Insider Trading Score
    Peer Group Scores
    VRDN
    83
    ARQT
    55
    ZVRA
    53
    RARE
    52
    PRAX
    50
    VTGN
    50
    SNDX
    39
    BCRX
    33
    BBIO
    32
    DNTH
    9
    TVTX
    7
    Recent Insider Trades
    Filing DateInsiderType10b5-1Net SharesOwnership changeAvg. PriceValueFiling
    2026-05-13
    Thompson Rahsaan
    Chief Legal & Compliance
    Sale
    -1,794
    -3.59%48,125
    $11.30$20,272View SEC filing
    2026-02-10
    McFarlane Neil F.
    President and CEO
    Sale
    -14,625
    -3.64%387,225
    $8.56$125,186View SEC filing
    2026-02-04
    Schafer Joshua
    CCO
    Sale
    -10,500
    -14.43%62,278
    $9.19$96,500View SEC filing
    2026-02-04
    Sangiovanni Timothy J.
    SVP, Finance & Corp Controller
    Sale
    -3,000
    -9.21%29,590
    $9.18$27,548View SEC filing
    2026-02-02
    Schafer Joshua
    CCO
    Sale
    -3,375
    -8.27%37,444
    $8.83$29,800View SEC filing
    2026-02-02
    Quartel Adrian W
    Chief Medical Officer
    Sale
    -4,533
    -31.80%9,723
    $8.83$40,036View SEC filing
    2026-02-02
    Thompson Rahsaan
    Chief Legal & Compliance
    Sale
    -4,080
    -7.56%49,919
    $8.83$36,010View SEC filing
    2026-02-02
    Sangiovanni Timothy J.
    SVP, Finance & Corp Controller
    Sale
    -1,750
    -7.72%20,924
    $8.82$15,442View SEC filing
    2026-02-02
    McFarlane Neil F.
    President and CEO
    Sale
    -91,000
    -19.98%364,350
    $9.38$853,425View SEC filing
    2025-10-10
    McFarlane Neil F.
    President and CEO
    Sale
    -19,500
    -8.07%222,016
    $10.82$210,908View SEC filing
    2025-09-16
    FAVORITO TAMARA A
    Director
    Purchase
    +3,175
    +441.59%3,894
    $7.79$24,718View SEC filing
    2025-09-15
    Shih Alvin
    Director
    Purchase
    +20,000
    +100.00%20,000
    $7.89$157,800View SEC filing
    2025-08-20
    Bode John B
    Director
    Purchase
    +5,000
    +12.50%45,000
    $9.16$45,825View SEC filing
    2025-06-30
    Thompson Rahsaan
    Chief Legal & Compliance
    Sale
    -24,000
    -36.00%42,666
    $9.21$221,004View SEC filing
    2025-03-31
    Watton Corey Michael
    Director
    Purchase
    +300
    +20.00%1,800
    $7.84$2,352View SEC filing
    2025-03-21
    Bode John B
    Director
    Purchase
    +10,000
    +33.33%40,000
    $7.96$79,624View SEC filing
    2025-02-14
    Sangiovanni Timothy J.
    SVP, Finance & Corp Controller
    Sale
    -3,000
    -15.51%16,341
    $7.86$23,588View SEC filing
    2025-02-14
    Schafer Joshua
    CCO & EVP, Bus. Development
    Sale
    -10,500
    -26.26%29,486
    $7.86$82,527View SEC filing
    2025-02-14
    Clifton R. LaDuane
    CFO & Treasurer
    Sale
    -11,000
    -17.64%51,361
    $7.86$86,471View SEC filing
    2025-02-14
    McFarlane Neil F.
    President and CEO
    Sale
    -91,817
    -32.41%191,516
    $7.92$727,390View SEC filing
    2024-10-16
    Watton Corey Michael
    Director
    Purchase
    +500
    +50.00%1,500
    $7.92$3,958View SEC filing
    2024-07-17
    Clifton R. LaDuane
    CFO & Treasurer
    Purchase
    +2,000
    +12.14%18,469
    $6.77$13,540View SEC filing
    2024-07-16
    Anderson Thomas
    Director
    Purchase
    +10,000
    +100.00%20,000
    $6.81$68,065View SEC filing
    2024-07-15
    Bode John B
    Director
    Purchase
    +10,000
    +50.00%30,000
    $5.87$58,661View SEC filing
    2023-09-06
    Schafer Joshua
    CCO & EVP, Bus. Development
    Purchase
    +500
    +16.67%3,500
    $5.13$2,565View SEC filing

    1-25 of 112

    Page 1 of 5